RedHill Biopharma (RDHL) Inventory (2017 - 2025)

RedHill Biopharma (RDHL) has 9 years of Inventory data on file, last reported at $3.2 million in Q2 2025.

• On a quarterly basis, Inventory fell 16.69% year-over-year to $3.2 million in Q2 2025; TTM through Jun 2025 was $3.2 million, a 16.69% decrease from a year earlier, with the FY2024 full-year figure at $3.7 million, down 16.81% from the prior year.
• Inventory for Q2 2025 stood at $3.2 million, down from $3.7 million in the prior quarter.
• Over the last five years, Inventory for RDHL reached as high as $14.8 million in Q4 2021 and fell as low as $3.2 million in Q2 2025.
• Historically, Inventory has averaged $8.7 million across 5 years, with a median of $9.0 million in 2021.
• Across the five-year window, Inventory soared 235.02% in 2021 and plunged 60.13% in 2023, its largest moves.
• Year by year, Inventory stood at $14.8 million in 2021, then declined by 25.67% to $11.0 million in 2022, then plunged by 60.13% to $4.4 million in 2023, then dropped by 16.81% to $3.7 million in 2024, then fell by 13.2% to $3.2 million in 2025.
• Per Business Quant data, the three most recent Inventory figures were $3.2 million in Q2 2025, $3.7 million in Q4 2024, and $3.8 million in Q2 2024.